/Lists

Biotech Investors & VC Firms in United States

1619 firms in this list, with a median first check of $500K. 402 of them lead rounds. Generated from verified public data and updated continuously.

D3 Jubilee
SeoulSeed–Series A
11 people
Georgian
Toronto, OntarioSeries C–Growth$25M – $100M
18 people
Planet 9 Capital
BergenSeed
3 people
Vento
TurinPre-Seed–Seed$150K – $1.1M
15 people
Cowin Capital Group
ShenzhenSeed–Growth
11 people
Decacorn Capital
SingaporeSeed–Series B$300K – $600K
17 people
Xeraya Capital
Kuala LumpurSeed–Growth
23 people
Pangaea Ventures Us Inc.
VancouverSeed–Series B$500K – $1.5M
15 people
Catalyst Investments, L.P.
Tel AvivGrowth–Late Stage$1.5M – $5M
29 people
Fly Ventures
BerlinPre-Seed–Series A$1.1M – $4.3M
6 people
ScaleX Ventures
AmsterdamPre-Seed–Series A$216K – $2.2M
15 people
Metavallon VC
AthensPre-Seed–Seed$216K – $1.6M
10 people
Lilly Asia Ventures
Hong KongPre-Seed–Series C
3 people
Magna Investment
SeoulSeed–Growth
17 people
Whiz Partners Inc.
TokyoSeed–Growth$500K – $5M
23 people
KOMPAS VC
HørsholmPre-Seed–Series B$1.1M – $5.4M
16 people
Nucleus Capital
BerlinPre-Seed–Seed$1M – $1.1M
21 people
LAV
Hong KongSeed–Series C$5M – $15M
3 people
Brightlands Venture Partners
GeleenSeed–Series B$540K – $2.2M
14 people
Nordic Capital
StockholmGrowth–Late Stage
17 people
Big Pi Ventures
AthensSeed–Growth$540K – $3.2M
19 people
Creator Fund
LondonPre-Seed–Seed$1.1M
22 people
2080 Ventures
Pre-Seed–Seed$100K – $500K
19 people
Saltagen Ventures
Hong KongSeed–Series B
21 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.